Nicole Ryan
Physician Assistant · Rensselaer, NYNPI 1831283548
Payments from drug & device makers
Across 368 payments — averaging $15.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$990
- GSK$855
- Boehringer Ingelheim$604
- AstraZeneca$443
- Novo Nordisk$394
- Lilly USA, LLC$392
- plus $2K from 34 others
What the payments were for
- Food & beverage$5,794100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,794 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 56 | $77,750 |
| JardianceEmpagliflozin | 48 | $52,566 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 65 | $48,308 |
| ProliaDenosumab | 13 | $22,814 |
| TrulicityDulaglutide | 16 | $20,884 |
| JanuviaSitagliptin Phosphate | 14 | $18,270 |
| JanumetSitagliptin Phos/Metformin Hcl | 25 | $18,101 |
| EliquisApixaban | 25 | $17,576 |
| RybelsusSemaglutide | 13 | $12,275 |
| OxycontinOxycodone Hcl | 23 | $11,824 |
| TrintellixVortioxetine Hydrobromide | 18 | $9,716 |
| LinzessLinaclotide | 12 | $6,532 |
| Spiriva RespimatTiotropium Bromide | 11 | $5,706 |
| MyrbetriqMirabegron | 12 | $5,378 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $4,976 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $394 | $90,02569 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $604 | $58,27359 claims |
| GSKTrelegy Ellipta | $855 | $48,30865 claims |
| MerckJanuvia, Janumet | $27 | $36,37139 claims |
| AmgenProlia | $153 | $22,81413 claims |
| Lilly USA, LLCTrulicity | $392 | $20,88416 claims |
| PfizerEliquis | $275 | $17,57625 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $201 | $9,71618 claims |
| AbbVieLinzess, Synthroid | $990 | $8,32639 claims |
| Astellas Pharma US IncMyrbetriq | $29 | $5,37812 claims |
| AstraZenecaSymbicort | $443 | $3,62416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Rensselaer
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
- Cameron KiserNew York$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.